Stock Movers: DBV Drug Approval, EU-US Trade Tensions, Venezuela Sanctions

DBV Technologies Peanut Allergy Patch Breakthrough

• 💡 DBV Technologies, a French biotech company, saw its shares surge over 40% following positive results from a trial for its experimental skin patch.
• ✅ The patch demonstrated success in desensitizing children aged 4-7 with peanut allergies over a year, a significant breakthrough after 20 years of work and previous setbacks.
• 🚀 DBV plans to seek US regulatory approval in the first half of 2026 for this potentially blockbuster product, addressing a large patient population.

US-EU Trade Tensions and Tech Retaliation

• ⚠️ The US administration has threatened retaliation, including potential fees or restrictions, against European firms in response to the EU's plan to tax big American tech companies.
• 🎯 Companies like SAP, Capgemini, Publicis, and DHL were singled out, leading to a dip in their shares, though the market reaction suggests the threats may not yet be fully concrete.
• 📈 Spotify, a Swedish-US listed company, also saw its shares fall due to these tensions, highlighting the ongoing friction between the US and EU.

Venezuela Sanctions and Oil Market Impact

• ⛽ President Trump ordered a blockade of sanctioned oil tankers going into and leaving Venezuela, increasing pressure on the country.
• 📈 This action boosted the price of crude oil, leading to gains for oil majors such as BP, Shell, and Total Energies.
• 🌍 While Venezuela is an OPEC member, its influence on global oil markets is limited, meaning the impact is more sentiment-driven than a fundamental supply shock.